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Poly(ADP-ribose) polymerase-1 (PARP1) plays a regulatory role in apoptosis, necrosis,
and other cellular processes after injury. Recently, we revealed that PARP1 regulates the
differential neuronal/astroglial responses to pilocarpine-induced status epilepticus (SE) in
the distinct brain regions. In addition, P2X7 receptor (P2X7R), an ATP-gated ion channel,
activation accelerates astroglial apoptosis, while it attenuates clasmatodendrosis
(lysosome-derived autophagic astroglial death). Therefore, we investigated whether
P2X7R regulates regional specific astroglial PARP1 expression/activation in response to
SE. In the present study, P2X7R activation exacerbates SE-induced astroglial apoptosis,
while P2X7R inhibition attenuates it accompanied by increasing PARP1 activity in the
molecular layer of the dentate gyrus following SE. In the CA1 region, however, P2X7R
inhibition deteriorates SE-induced clasmatodendrosis via PARP1 activation following
SE. Taken together, our findings suggest that P2X7R function may affect SE-induced
astroglial death by regulating PARP1 activation/expression in regional-specific manner.
Therefore, the selective modulation of P2X7R-mediated PARP1 functions may be a
considerable strategy for controls in various types of cell deaths.
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Introduction
It has been reported that astroglial death/damage occurs following epilepsy, brain ischemia and
Alzheimer’s diseases (Liu et al., 1999; Kang et al., 2006; Olabarria et al., 2010). In particular, status
epilepticus (SE) induces the regional specific astroglial death (Kang et al., 2006; Kim et al., 2008;
Kim and Kang, 2011; Ryu et al., 2011a,b). Briefly, caspase-independent apoptotic astroglial death
is observed in the molecular layer of the dentate gyrus (Kang et al., 2006; Kim et al., 2010). In
contrast, astroglial death in the CA1 region shows extensive swelling and vacuolization of cell
bodies, and/or disintegrated and beaded processes in the CA1 region (Kim et al., 2008; Kim and
Kang, 2011). This irreversible astroglial degeneration is first reported by Alzheimer in 1910, termed
‘‘clasmatodendrosis’’ by Cajal (Penfield, 1928), and is relevant to lysosome-derived autophagy (Ryu
et al., 2011a,b).
P2X7 receptor (P2X7R), an ATP-gated ion channel, regulates the release of gliotransmitters and
cytokines/chemokines from neuroglia (Le Feuvre et al., 2003; Parvathenani et al., 2003; Melani
et al., 2005; McLarnon et al., 2006). Interestingly, P2X7R activation accelerates astroglial apoptosis,
while it attenuates clasmatodendrosis (Kim et al., 2011). However, P2X7R function does not
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affect astroglial loss in the piriform cortex (PC, Kim et al., 2011).
Therefore, it is likely that at least in the hippocampus P2X7Rmay
be one of the fundamental effectors for regional specific astroglial
loss induced by SE.
Poly(ADP-ribose) polymerase-1 (PARP1) repairs DNA
damage following various injuries. Therefore, PARP1
plays an important role in anti-apoptotic events. Indeed,
full-length PARP1 is cleaved by the apoptotic proteases
(caspase-3 and -7) into p85 and p25 fragments during
apoptosis (Kaufmann et al., 1993; Lazebnik et al., 1994).
Furthermore, the down-regulation of PARP1 expression
(PARP1 degradation without cleavage into apoptotic fragments)
is mediated by caspase-independent ubiquitylation that plays
a regulatory role in apoptosis, necrosis and other PARP1-
regulated cellular processes (Guillouf et al., 2000; Wang
et al., 2008; Matsushima et al., 2011; Nagai et al., 2012).
However, PARP1 over-activation also causes necrotic cell
death induced by NAD+-depleted energy failure, since
PARP1 utilizes NAD+ to form PAR during DNA repairs
(Berger, 1985; Zhang et al., 1994; Szabó and Dawson, 1998;
Ha and Snyder, 1999; Virág and Szabó, 2002; Ying et al.,
2002). Therefore, it is likely that the distinct profiles of
PARP1 (activation, cleavage or degradation) may involve the
differential cellular responses to harmful stimuli. Recently,
we have reported that PARP1 degradation is observed in
astrocytes within the molecular layer of the dentate gyrus,
while PARP1 induction is detected in CA1–3 reactive
astrocytes. Furthermore, PARP1 inhibitors deteriorate the
SE-induced astroglial death in the molecular layer of the
dentate gyrus independently of hemodynamics (Kim et al.,
2014). Therefore, PARP1 activation/degradation may distinctly
involve regional-specific astroglial death in response to SE,
although the mechanism has not been fully understood.
With respect to the role of P2X7R in SE-induced astroglial
degeneration, it is plausible that P2X7R may involve astroglial
PARP1 degradation/activation in response to SE. In order to
address this hypothesis, we investigated the role of P2X7R in
PARP1-mediated regional specific astroglial death induced
by SE.
Materials and Methods
Experimental Animals and Chemicals
This study utilized the progeny of Sprague-Dawley (SD)
rats (male, 9–11 weeks old) obtained from Experimental
Animal Center, Hallym University, Chuncheon, South Korea.
The animals were provided with a commercial diet and
water ad libitum under controlled temperature, humidity
and lighting conditions (22 ± 2◦C, 55 ± 5% and a
12:12 light/dark cycle with lights). Animal protocols were
approved by the Institutional Animal Care and Use Committee
of Hallym University (No. 2013-107). Procedures involving
animals and their care were conducted in accord with our
institutional guidelines that comply with NIH Guide for
the Care and Use of Laboratory Animals (NIH Publications
No. 80-23, 1996). The number of animals used and their
suffering were minimized in all cases. All reagents were
obtained from Sigma-Aldrich (St. Louis, MO, USA), except as
noted.
Intracerebroventricular Drug Infusion
Rats were divided into four groups: vehicle (saline) treated, 2′,3′-
O-(4-benzoylbenzoyl)-adenosine 5′-triphosphate (BzATP,
P2X7R agonist, 5 mM, Sigma) treated, adenosine
5′-triphosphate-2′,3′-dialdehyde (OxATP, P2X7R antagonist,
5 mM, Sigma) treated and A740003 (P2X7R antagonist, 5 mM,
Sigma) treated groups. The dosage of each compound was
determined as the highest dose that did not affect seizure
threshold in previous study (Kim et al., 2011). Animals were
anesthetized using isoflurane and placed in a stereotaxic
frame. For the osmotic pump implantation, holes were
drilled through the skull for introducing a brain infusion
kit 1 (Alzet, USA) into the right lateral ventricle (1 mm
posterior; 1.5 mm lateral; −3.5 mm depth; flat skull position
with bregma as reference), according to the atlas of Paxinos
and Watson (1997). The infusion kit was sealed with dental
cement and connected to an osmotic pump (1007D, Alzet,
USA). The pump was placed in a subcutaneous pocket in
the dorsal region. Animals received 0.5 µl/h of vehicle or
compound for 1 week (Siuciak et al., 1996; Pencea et al.,
2001).
Seizure Induction
One week after surgery, rats were treated with pilocarpine
(380 mg/kg, i.p.) 20 min after injection of methyl scopolamine
(5 mg/kg, i.p.). Approximately 80% of pilocarpine treated rats
showed acute behavioral features of SE (including akinesia, facial
automatisms, limbic seizures consisting of forelimb clonus with
rearing, salivation, masticatory jaw movements, and falling).
Diazepam (10 mg/kg, i.p.) was administered 2 h after onset
of SE and repeated, as needed. At designated time courses
(3 days and 4 weeks after SE; n = 15, respectively), animals
were used for immunohistochemistry. Non-experienced SE
rats (showed only acute seizure behaviors during 10–30 min,
n = 11) and age-matched normal rats were used as controls
(n = 8).
Tissue Processing
Animals were perfused transcardially with phosphate-buffered
saline (PBS) followed by 4% paraformaldehyde in 0.1 M
phosphate buffer (PB, pH 7.4) under urethane anesthesia
(1.5 g/kg, i.p.). The brains were removed, and postfixed in the
same fixative for 4 h. The brain tissues were cryoprotected by
infiltration with 30% sucrose overnight. Thereafter, the entire
hippocampus was frozen and sectioned with a cryostat at
30 µm and consecutive sections were contained in six-well plates
containing PBS. For stereological study, every sixth section in
the series throughout the entire hippocampus was used in some
animals.
Immunofluorescence Staining
To identify the morphological changes induced by SE in
the same hippocampal tissue, double immunofluorescence
staining was performed. Brain tissues were incubated with a
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mixture of mouse anti-GFAP IgG (diluted 1:100; Millipore,
Bedford, MA, USA)/rabbit anti-PARP1 IgG (diluted 1:100;
Abnova), rabbit anti-GFAP IgG (diluted 1:200; Promega,
Madison, WI, USA)/mouse anti-PAR IgG (diluted 1:100;
Trevigen, Gaithersburg, MD, USA) or mouse anti-GFAP
IgG/rabbit anti-lysosomal-associated membrane protein-1
(LAMP1) IgG (diluted 1:100; Abcam, USA) overnight at
room temperature. After washing three times for 10 min
with PBS, sections were also incubated in a mixture of
FITC- and Cy3-conjugated secondary antisera (Amersham,
USA, 1:200) for 1 h at room temperature. Sections were
mounted in Vectashield mounting media with/without DAPI
(Vector, Burlingame, CA, USA). Images were captured using
an AxiocamHRc camera and Axio Vision 3.1 software or
Bio-Rad MRC 1024 Confocal Microscope System (Bio-
Rad Laboratories, 2000 Alfred Nobel Drive, Hercules, CA
94547, USA). Figures were mounted with Adobe PhotoShop
7.0 (San Jose, CA, USA). Manipulation of the images was
restricted to threshold and brightness adjustments to the whole
image.
Cell Counts
For quantification of immunohistochemical data, Cells in
2–4 regions (1 × 105µm2) from each section were counted
on 20 × images. Results are presented as means ± SEM
of 15–24 regions from five animals. For quantification of
PARP1, PAR or LAMP1 in astrocytes, immunofluorescent
images (10 sections/rat) were captured (500 × 500 µm).
Images were sampled from at least five different points within
each section. Thereafter, the number of GFAP positive cells
showing PARP1, PAR or LAMP1 induction was actually
counted within the sampled images. All immunoreactive
cells were counted regardless the intensity of labeling. Cell
counts were performed by two different investigators who
were blind to the classification of tissues. All data obtained
from the quantitative measurements were analyzed using one-
way ANOVA to determine statistical significance. Bonferroni’s
test was used for post hoc comparisons. A p-value below
0.05 was considered statistically significant (Kim et al., 2008,
2009).
Results
P2X7R does not Affect Neuronal PARP1
Expression in Response to SE
Recently, we have reported that PARP1 activation/expression
shows regional- and cellular specific responses to seizure in a
hemodynamic-independent manner (Kim et al., 2014). Thus,
we investigated whether P2X7R activity affects the SE-induced
changes of PARP1 expression in neurons. Figure 1A shows
that PARP1 expression was evenly observed in CA1–3 neurons
as well as dentate granule cells in non-SE animals. In non-
SE animals, P2X7R agonist and antagonist infusion did not
affect neuronal PARP1 expression and neuronal viability in the
hippocampus (data not shown). Consistent with our previous
study (Kim et al., 2014), PARP1 expression was down-regulated
in CA1 neurons 1 week after SE (p < 0.05 vs. non-SE animals;
Figures 1B,E). However, PARP1 expression was unaltered in
dentate granule cells in this time window (Figure 1F). Both
BzATP and OxATP infusion did not affect neuronal PARP1
expression in the hippocampus 1 week after SE (Figures 1C–F).
These findings indicate that P2X7R may not be involved in
PARP1-mediated neuronal death induced by SE.
P2X7R Antagonists Prevent PARP1-Medaited
Astroglial Death in the Dentate Gyrus
Following SE
To confirm the role of P2X7R in astroglial death in the dentate
gyrus, we applied P2X7R agonist (BzATP) and antagonist
(OxATP or A7400036) infusion prior to SE induction. Consistent
with our previous study (Kim et al., 2011), P2X7R agonist and
antagonist infusion did not lead to astroglial apoptosis in the
hippocampus of non-SE animal (data not shown). One week
after SE, typical reactive astrogliosis was observed in the stratum
radiatum of the CA1 region (Figures 1B,C). However, massive
astroglial loss was detected within the molecular layer of the
dentate gyrus in this time point. In vehicle-infused animals,
the number of astroglial cells was reduced to 42% of that in
non-SE animals (p < 0.05 vs. non-SE animals; Figures 1B,G).
In BzATP-infused animals, the number of astroglial cells was
reduced to 30% of that in non-SE induced animals (p < 0.05
vs. vehicle-treated animals; Figures 1C,G). In OxATP-infused
animals, the number of astroglial cells was 94% of that in
non-SE animals (Figures 1D,G). The effect of A740003 on
astroglial responses to SE was similar to that of OxATP
(data not shown). Consistent with our previous studies (Kim
et al., 2011), these findings indicate that P2X7R activation may
exacerbate SE-induced astroglial death, while P2X7R inhibition
may attenuate it in the molecular layer of the dentate gyrus
following SE.
SE-induced down-regulation of PARP1 expression results
in astroglial death within the molecular layer of the dentate
gyrus (Kim et al., 2014). Therefore, we investigated whether
P2X7R is involved in PARP1-mediated astroglial death in this
region following SE. In non-SE animals, 51% of astrocytes
showed PARP1 expression in the molecular layer of the
dentate gyrus (Figures 2A,F). P2X7R agonist and antagonist
infusion did not affect astroglial PARP1 expression in the
hippocampus of non-SE animal (data not shown). One week
after SE, 10% astrocytes showed PARP1 expression (p < 0.05
vs. non-SE animals; Figures 2B,F). BzATP did not affect SE-
induced astroglial PARP1 expression as compared to vehicle
(p < 0.05 vs. non-SE animals; Figures 2C,F). In contrast
to BzATP, both OxATP and A740003 effectively prevented
the down-regulation of astroglial PARP1 expression as well
as astroglial loss induced by SE (p < 0.05 vs. vehicle;
Figures 2D–F).
Since PAR is a metabolite of PARP1 (Zhang et al., 1994;
Virág and Szabó, 2002; Ying et al., 2002), we also performed
Immunohistochemistry for PAR to investigate astroglial PARP1
activity. Consistent with our previous study (Kim et al.,
2014), PAR immunoreactivity was detected only in the dentate
granule cells 1 week after SE (Figures 3A,B). Although BzATP
did not affect astroglial PAR synthesis (Figure 3C), both
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 September 2015 | Volume 9 | Article 352
Kim et al. P2X7R-mediated PARP1 activity in astrocytes
FIGURE 1 | The effects of P2X7R agonist and antagonist on PARP1 expression in the hippocampus 1 week after status epilepticus (SE). As compared
to non-SE animals, PARP1 expression is decreased in CA1 neurons, but not dentate granule cells (A,B). Neither BzATP nor OxATP affects reduction in PARP1
expression in the CA1 neurons following SE (C,D). Furthermore, SE reduces the number of astrocytes in the molecular layer of the dentate gyrus. BzATP deteriorates
SE-induced astroglial loss in this region, while OxATP prevents it (A–D). Bar = 300 µm. (E,F) Quantification of PARP1 intensity in the CA1 (E) and dentate granule
cells (F) and the number of astrocytes in the molecular layer of the dentate gyrus (G) following SE (means ± s.d., n = 5, respectively). *p < 0.05 vs. non-SE animals
(one-way ANOVA test).
OxATP and A740003 increased astroglial PAR levels in this
time point (p < 0.05 vs. vehicle; Figures 3D–F). Therefore,
23- and 24% of astrocytes showed PAR immunoreactivity
in OxATP and A740003-treated animals, respectively. Neither
OxATP nor A740003 affected neuronal PAR level in this
time window (Figures 3D–F). These findings indicate that
P2X7R inhibition may prevent astroglial loss by increasing
PARP1 activity in the molecular layer of the dentate gyrus
following SE.
P2X7R Inhibitors Aggravate Autophagic
Astroglial Death with PARP1 Activation in the
CA1 Region
Clasmatodendrosis is characterized by round-shaped edematous
cell body, short blunt processes, vacuolization and GFAP
tangles in the cytoplasm and nuclear dissolution. In addition,
vacuoles in clasmatodendritic astrocytes showed LAMP1
(a marker for lysosome) immunoreactivity, not GM130
(a maker for Golgi apparatus) or EEA-1 (a marker for
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FIGURE 2 | The effects of P2X7R agonist and antagonist on PARP1 expression in astrocytes within the molecular layer of the dentate gyrus 1 week
after SE. As compared to non-SE animals (A), vehicle-treated animals show the astroglial loss in the molecular layer of the dentate gyrus accompanied by reduction
of PARP1 expression (B). BzATP deteriorates astroglial death and astroglial PARP1 degradation following SE (C). Both OxATP and A740003 effectively prevent
astroglial death with the preservation of astroglial PARP1 expression (D,E). Insertions (in A,D,E) are high magnification of rectangles. Bar = 50 and 25 (insertion) µm.
(F) The fraction of PARP1 positive astrocytes in the total number of astrocytes within the molecular layer of the dentate gyrus (means ± s.d., n = 5, respectively).
∗p < 0.05 vs. non-SE animals (one-way ANOVA test).
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FIGURE 3 | The effects of P2X7R agonist and antagonist on PARP1 activity in the molecular layer of the dentate gyrus 1 week after SE. PAR synthesis
is detected only in dentate granule cells (A,B). BzATP does not affect astroglial PAR synthesis induced by SE (C). Both OxATP and A740003 increase astroglial PAR
expression following SE (D,E). Bar = 50 µm. (F) The fraction of PAR positive astrocytes in the total number of astrocytes within the molecular layer of the dentate
gyrus (means ± s.d., n = 5, respectively). ∗p < 0.05 vs. non-SE animals (one-way ANOVA test).
endosome) immunoreactivity. Therefore, clasmatodendrosis
is the slow astroglial death induced by lysosome-derived
autophagy (Ryu et al., 2011a,b). Unlike apoptotic astroglial
death in the molecular layer of the dentate gyrus, however,
the role of PARP1 in clasmatodendrosis is unknown.
Thus, we investigated whether P2X7R-mediated PARP1
activation/expression is involved in this autophagic astroglial
death, since P2X7R inhibition accelerates clasmatodendrosis
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FIGURE 4 | The effects of P2X7R agonist and antagonist on clasmatodendrosis in the stratum radiatum of the CA1 region 4 weeks after SE. SE
induces lysosomal-associated membrane protein-1 (LAMP1) positive clasmatodendrosis in the CA1 region (A,B). BzATP effectively reduces the number of LAMP1
positive clasmatodendritic astrocytes (C). Both OxATP and A490003 aggravate LAMP1 positive clasmatodendrosis (D,E). Bar = 25 µm. (F) The fraction of LAMP1
positive astrocytes in the total number of astrocytes within the CA1 region (means ± s.d., n = 5, respectively). ∗p < 0.05 vs. non-SE animals (one-way ANOVA test).
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in the CA1 region (Kim et al., 2011). Consistent with our
previous study (Kim et al., 2011), P2X7R agonist and
antagonist infusion did not result in clasmatodendrosis
in the CA1 region of non-SE animal (data not shown).
Four weeks after SE, 6.1% of astrocytes showed typical
clasmatodendrosis (loss of distal process and vacuolization
in cell body) containing strong LAMP1 expression in the
stratum radiatum of the CA1 region of vehicle-treated
animals (p < 0.05 vs. non-SE animals; Figures 4A,B,F).
While BzATP inhibited clasmatodendrosis (p < 0.05 vs. vehicle;
Figures 4C,F), OxATP and A740003 increased the number of
clasmatodendritic astrocytes in total astrocytes (p < 0.05 vs.
vehicle; Figures 4D–F). In addition, both P2X7R antagonists
significantly reduced the total number of astrocytes in the
CA1 region as compared to vehicle (p < 0.05 vs. vehicle;
Figure 4F).
Next, we investigated whether P2X7R regulates astroglial
PARP1 expression/activity. PARP1 expression was obviously
detected in the nuclei of reactive astrocytes, but not in the
nuclei of clasmatodendritic astrocytes (Figures 5A–C). BzATP
FIGURE 5 | The effects of P2X7R agonist and antagonist on astroglial PARP1 expression in the stratum radiatum of the CA1 region 4 weeks after SE.
PARP1 expression is rarely detected in astrocytes of non-SE animals (A). Following SE, PARP1 expression is observed in reactive astrocytes (B), not in
clasmatodendritic astrocytes (C). BzATP increases PARP1 expression in reactive astrocytes (D). Both OxATP and A740003 cannot induce PARP1 expression in
clasmatodendritic astrocytes (E,F). Bar = 12.5 µm.
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 September 2015 | Volume 9 | Article 352
Kim et al. P2X7R-mediated PARP1 activity in astrocytes
FIGURE 6 | The effects of P2X7R agonist and antagonist on astroglial PARP1 activity in the stratum radiatum of the CA1 region 4 weeks after SE. PAR
synthesis is rarely detected in astrocytes of non-SE animals (A). Following SE, PAR synthesis is observed in clasmatodendritic astrocytes (B). BzATP inhibits PAR
synthesis in astrocytes. Both OxATP and A740003 increase the number of PAR positive astrocytes (C–E). Bar = 25 µm. (F) The fraction of PAR positive astrocytes in
the total number of astrocytes within the CA1 region (means ± s.d., n = 5, respectively). ∗p < 0.05 vs. non-SE animals (one-way ANOVA test).
effectively prevented clasmatodendrosis accompanied by
preservation of the nuclear PARP1 expression, although
P2X7R antagonists did not (Figures 5D–F). As compared
to naïve astrocytes in non-SE animals, clasmatodendritic
astrocytes showed PAR immunoreactivity (Figures 6A,B,F).
BzATP effectively prevented astroglial PAR synthesis
induced by SE (p < 0.05 vs. vehicle; Figures 6C,F). In
contrast, OxATP and A740003 increased the fraction
of PAR-positive clasmatodendritic astrocytes in total
astrocytes to 25.6 and 26.1% respectively (p < 0.05 vs.
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FIGURE 7 | The effects of P2X7R agonist and antagonist on LAMP1 expression in reactive astrocytes within the molecular layer of the dentate gyrus
4 weeks after SE. In non-SE animals, LAMP1 positive astrocytes are not observed in the molecular layer (A). SE induces astroglial LAMP1 expression (B), and
BzATP does not affect it (C). However, both OxATP and A740003 increase the number of LAMP1 positive astrocytes in the molecular layer of the dentate gyrus
(D,E). Bar = 50 µm. (F) The fraction of LAMP1 positive astrocytes in the total number of astrocytes within the molecular layer of the dentate gyrus (means ± s.d.,
n = 5, respectively). ∗p < 0.05 vs. non-SE animals (one-way ANOVA test).
vehicle; Figures 6D–F). In the molecular layer of the
dentate gyrus, OxATP and A740003 also increased the
fraction of PAR- and LAMP1 positive astrocytes in
total astrocytes 4 weeks after SE (p < 0.05 vs. vehicle;
Figures 7, 8). However, both OxATP and A740003
did not induce clasmatodendrosis and astroglial loss
in this region (Figures 7, 8). These findings indicate
that P2X7R antagonism may increase astroglial PARP1
activity and autophagic process in the hippocampus
following SE.
Frontiers in Cellular Neuroscience | www.frontiersin.org 10 September 2015 | Volume 9 | Article 352
Kim et al. P2X7R-mediated PARP1 activity in astrocytes
FIGURE 8 | The effects of P2X7R agonist and antagonist on PARP1 activity in reactive astrocytes within the molecular layer of the dentate gyrus
4 weeks after SE. PAR-positive astrocytes are not observed in the molecular layer within the dentate gyrus of non-SE (A), vehicle-treated (B) and BzATP-treated
(C) animals. Both OxATP and A740003 increase the number of PAR positive astrocytes in the molecular layer of the dentate gyrus (D,E). Bar = 50 µm. (F) The
fraction of PAR positive astrocytes in the total number of astrocytes within the molecular layer of the dentate gyrus (means ± s.d., n = 5, respectively). ∗p < 0.05 vs.
non-SE animals (one-way ANOVA test).
PARP1 Inhibition Attenuates SE-Induced
Clasmatodendrosis in the CA1 Region
To confirm whether the enhancement of astroglial PARP1
activity leads to clasmatodendrosis in the CA1 region, we applied
two PARP1 inhibitors (PJ-34 and DPQ) 2 week after SE. Both
PJ-34 and DPQ effectively alleviated astroglial PAR synthesis
and clasmatodendrosis in the CA1 region 4 weeks after SE (p <
0.05 vs. vehicle; Figure 9). These findings suggest that PARP1
activation may be involved in SE-induced astroglial autophagic
process.
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FIGURE 9 | The effects of PARP1 inhibitors (DPQ and PJ-34) on LAMP1 or PAR positive astroglial responses in the stratum radiatum of the CA1
region 4 weeks after SE. Both PARP1 inhibitors reduce LAMP1 positive clasmatodendrosis (A–C) and PAR synthesis (D–F), as compared to vehicle. (G) The
numbers of clasmatodendritic and PAR-positive astrocytes in the stratum radiatum of the CA1 region (means ± s.d., n = 5, respectively). ∗p < 0.05 vs.
vehicle-treated animals (one-way ANOVA test). Bar = 50 µm.
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Discussion
Astroglial death/dysfunction involves the pathophysiology of
various neurological diseases (Briellmann et al., 2002; Vessal
et al., 2005; Kang et al., 2006). In particular, SE results in the
regional-specific astroglial damage characterized by a pattern of
selective vulnerability (Schmidt-Kastner and Ingvar, 1994, 1996;
Borges et al., 2003; Kang et al., 2006; Kim et al., 2010, 2011).
However, the molecular events underlying the occurrence of
SE-induced astroglial death has been unknown. In the present
study, P2X7R agonist and its antagonists could not induce
apoptotic astroglial loss in naïve astrocytes in non-SE animals.
However, P2X7R inhibition prevented SE-induced astroglial loss
accompanied by preservation of PARP1 expression and PAR
synthesis in the molecular layer of the dentate gyrus, where
acute astroglial apoptosis is observed 3–7 days after SE (Kim
et al., 2010, 2011). Unlike neurons, this SE-induced astroglial
apoptosis is mediated by apoptosis inducing factor (AIF). AIF
is synthesized in the cytosol as a 67 kDa precursor protein
and cleaved to produce a 57 kDa protein once transported
into the mitochondria (Candé et al., 2002). Under pathological
conditions, a soluble 57 kDa AIF protein translocates into the
nucleus where it results in chromatin condensation and DNA
fragmentation via caspase-independent manners (Joza et al.,
2001; Candé et al., 2004; Cregan et al., 2004). PARP1 activation
leads to cytosolic NAD+ depletion and mitochondrial release of
AIF, and restoration of cytosolic NAD+ through P2X7R prevents
release of AIF induced by PARP1 activation in vitro (Alano
et al., 2004, 2010). Therefore, it would be likely that PARP1
activation might be involved in astroglial apoptosis in the dentate
gyrus. However, PARP1 inhibitors cannot prevent SE-induced
apoptotic astroglial death in vivo (Kim et al., 2014). In addition,
the present data show that P2X7R antagonists prevented SE-
induced astroglial loss in the dentate gyrus accompanied by
the preservation of PARP1 expression, which may subsequently
facilitate PARP1-mediated DNA repairs in astrocytes (Kaufmann
et al., 1993; Lazebnik et al., 1994). Therefore, it is likely that SE-
induced astroglial apoptosis may be PARP1 activity-independent
processes.
In contrast to apoptotic event, clasmatodendrosis is relevant
to severe intracellular acidosis that is relatively slow events
(Kraig and Chesler, 1990; Hulse et al., 2001). This intracellular
acidification induces clasmatodendrosis during hyperglycemic
and energy failure (Friede and Van Houten, 1961; Kraig and
Chesler, 1990; Hulse et al., 2001). In the present study, P2X7R
agonist and its antagonists could not provoke clasmatodendrosis
in naïve astrocytes in non-SE animals. However, we found that
P2X7R antagonists promoted clasmatodendrosis, while P2X7R
agonist prevented it 4 weeks after SE. Since P2X7R activation
opens pannexin-1, which is one of hemichannel as a passage
for NAD+ (Alano et al., 2004, 2010; Kim and Kang, 2011), the
blockade of P2X7R may result in cytosolic NAD+ accumulation
and prolonged PARP1 activation. However, excessive PARP1
activation leads to intracellular acidification with release of
protons during hydrolysis of NAD+ to PAR (Affar el et al.,
2002). Therefore, it is likely that PARP1 over-activation induced
by SE in CA1 astrocytes may be an important factor inducing
clasmatodendrosis through intracellular acidification. Indeed,
the present study shows that both PARP1 inhibitors (PJ-34 and
DPQ) effectively alleviated PAR synthesis and clasmatodendrosis
in the CA1 region. Taken together, our findings indicate
that blockade of P2X7R may accelerate astroglial autophagic
processes by reinforcing PARP1-induced intracellular acidosis in
astrocytes following SE.
In the present study, however, clasmatodendritic astrocytes
showed PAR synthesis without nuclear PARP1 expression.
Morphologically, clasmatodendritic astrocytes have edematous
eosinophilic cytoplasm and large-sized vacuoles with pyknotic
nucleus or without nucleus (Kim et al., 2009). This morphology
of clasmatodendritic astrocytes is similar to that of ghost
cells retaining their size and shape with digested nuclei,
which are a consequence of coagulative necrosis (Kerr et al.,
1972; Kim et al., 2009). Indeed, autophagy undergoes a
change resembling coagulative necrosis (Searle et al., 1975;
Kim et al., 2009; Ryu et al., 2011b). Therefore, absence of
PARP1 expression may be due to the nuclear digestion during
autophagic processes. Since ghost cells have a potentially
much greater capacity to synthesize PAR (Benjamin and Gill,
1980), it is not surprising that clasmatodendritic astrocytes
showed the amount of PAR synthesis without PARP1
expression.
Interestingly, the present data demonstrate that P2X7R
antagonists also increased astroglial PARP1 activity and LAMP1
expression in the dentate gyrus 4 weeks after SE, although they
did not induce clasmatodendrosis unlike CA1 astrocytes. These
findings indicate that astrocytes in the dentate gyrus may be
resistant to clasmatodendritic degeneration induced by P2X7R-
mediated PARP1 activation, and also support the hypothesis that
the susceptibility of astrocytes in response to SE is most likely
due to the distinctive anatomical and physiological heterogeneity
of astrocytes independent of hemodynamics.
In conclusion, the present study provides novel evidence
that P2X7R function may affect SE-induced astroglial death
by regulating PARP1 activation/expression in regional-specific
manner. To the best of our knowledge, the present study
demonstrates for the first time the relationship between P2X7R
and PARP1 functions during SE-induced astroglial death.
Therefore, we suggest that the selective modulation of P2X7R-
mediated PARP1 functions may be a considerable strategy for
controls in various types of cell deaths.
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